BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Guanfacine Hydrochloride

A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

8+ PubMed studies analyzed · 4 RCTs · Evidence Score: 51.4

Research Domains

Guanfacine Hydrochloride has been studied across 3 research domains including 🧠 Focus & Attention, ❤️ Cardiovascular, 🌤️ Mood & Depression. The primary research focus is 🧠 Focus & Attention with 63% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Guanfacine Hydrochloride, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Mephenesin
3 shared targets
Darunavir
3 shared targets
Niceritrol
2 shared targets
Sulfaphenazole
3 shared targets
Tetracycline
3 shared targets
Dehydrocholic
2 shared targets
Carbimazole
2 shared targets
Methoxsalen
4 shared targets
Moricizine
2 shared targets
Ranitidine
3 shared targets
Loading evidence profile...

This evidence profile for Guanfacine Hydrochloride is generated deterministically from 8 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.